Gregory’s Pediatric Anesthesia
Chapter 33 - References
1. Fitzgerald M, Walker SM. Infant pain management: a developmental neurobiological approach. Nat
Clin Pract Neurol 2009; 5(1): 35–50.
2. Fitzgerald M. The post-natal development of cutaneous afferent fibre input and receptive field
organization in the rat dorsal horn. J Physiol (Lond) 1985; 364: 1–18.
3. Fitzgerald M, Koltzenburg M. The functional development of descending inhibitory pathways in the
dorsolateral funiculus of the newborn rat spinal cord. Dev Brain Res 1986; 24: 261–70.
4. Slater R, Boyd S, Meek J, Fitzgerald M. Cortical pain responses in the infant brain. Pain 2006;
123(3): 332.
5. Marsh D, Dickenson A, Hatch D, Fitzgerald M. Epidural opioid analgesia in infant rats I: mechanical
and heat responses. Pain 1999; 82(1): 23–32.
6. Westin BD, Walker SM, Deumens R, Grafe M, Yaksh TL. Validation of a preclinical spinal safety
model: effects of intrathecal morphine in the neonatal rat. Anesthesiology 2010; 113(1): 183–99.
7. Batra YK, Rakesh SV, Panda NB, Lokesh VC, Subramanyam R. Intrathecal clonidine decreases
propofol sedation requirements during spinal anesthesia in infants. Paediatr Anaesth 2010; 20(7): 625–
32.
8. Rochette A, Troncin R, Raux O et al. Clonidine added to bupivacaine in neonatal spinal anesthesia:
a prospective comparison in 124 preterm and term infants. Paediatr Anaesth 2005; 15(12): 1072–7.
9. Taddio A, Katz J, Ilersich AL, Koren G. Effect of neonatal circumcision on pain response during
subsequent routine vaccination. Lancet 1997; 349(9052): 599–603.
10. Anand KJ, Coskun V, Thrivikraman KV, Nemeroff CB, Plotsky PM. Long-term behavioral effects of
repetitive pain in neonatal rat pups. Physiol Behav 1999; 66(4): 627–37.
11. Anand KJS, Sippell WG, Aynsley-Green A. A randomised trial of fentanyl anaesthesia in preterm
neonates undergoing surgery: effects on the stress response. Lancet 1987; 1(8524): 62–6.
12. Anand KJ, Sippell WG, Schofield NM, Aynsley-Green A. Does halothane anaesthesia decrease the
metabolic and endocrine stress responses of newborn infants undergoing operation? BMJ Clin Res Ed
1988; 296(6623): 668–72.
13. Anand KJS, Hansen DD, Hickey PR. Hormonal–metabolic stress responses in neonates
undergoing cardiac surgery. Anesthesiology 1990; 73(4): 661–70.
14. Anand KJ, Hickey PR. Halothane–morphine compared with high-dose sufentanil for anesthesia and
postoperative analgesia in neonatal cardiac surgery. N Engl J Med 1992; 326(1): 1–9.
15. Simons SH, van Dijk M, van Lingen RA et al. Routine morphine infusion in preterm newborns who
received ventilatory support: a randomized controlled trial. JAMA 2003; 290(18): 2419–27.
16. McGrath PJ, Walco GA, Turk DC et al. Core outcome domains and measures for pediatric acute
and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain 2008; 9(9): 771–83.
17. Berde C, McGrath P. Pain measurement and Beecher's challenge: 50 years later. Anesthesiology
2009; 111(3): 473–4.
18. Stevens B, Johnston C, Petryshen P, Taddio A. Premature Infant Pain Profile: development and
initial validation. Clin J Pain 1996; 12(1): 13–22.
19. Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: a behavioral scale for scoring
postoperative pain in young children. Pediatr Nurs 1997; 23(3): 293–7.
20. Malviya S, Voepel-Lewis T, Burke C, Merkel S, Tait AR. The revised FLACC observational pain
tool: improved reliability and validity for pain assessment in children with cognitive impairment. Paediatr
Anaesth 2006; 16(3): 258–65.
21. Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The Faces Pain Scale –
Revised: toward a common metric in pediatric pain measurement. Pain 2001; 93(2): 173–83.
22. Bulloch B, Garcia-Filion P, Notricia D, Bryson M, McConahay T. Reliability of the color analog
scale: repeatability of scores in traumatic and nontraumatic injuries. Acad Emerg Med 2009; 16(5):
465–9.
23. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental
pharmacology – drug disposition, action, and therapy in infants and children. N Engl J Med 2003;
349(12): 1157–67.
24. Cohen G, Malcolm G, Henderson-Smart D. Ventilatory response of the newborn infant to mild
hypoxia. Pediatr Pulmonol 1997; 24(3): 163–72.
25. Bissonnette JM. Mechanisms regulating hypoxic respiratory depression during fetal and postnatal
life. Am J Physiol Regul Integr Compar Physiol 2000; 278(6): R1391–400.
26. Anwar M, Marotta F, Fort MD et al. The ventilatory response to carbon dioxide in high risk infants.
Early Hum Dev 1993; 35(3): 183–92.
27. Morton NS, Errera A. APA national audit of pediatric opioid infusions. Paediatr Anaesth 2010;
20(2): 119–25.
28. Telleria-Diaz A, Schmidt M, Kreusch S et al. Spinal antinociceptive effects of cyclooxygenase
inhibition during inflammation: involvement of prostaglandins and endocannabinoids. Pain 2010;
148(1): 26–35.
29. Ririe DG, Prout HD, Barclay D, Tong C, Lin M, Eisenach JC. Developmental differences in spinal
cyclooxygenase 1 expression after surgical incision. Anesthesiology 2006; 104(3): 426–31.
30. Warner TD, Vojnovic I, Giuliano F, Jimenez R, Bishop-Bailey D, Mitchell JA. Cyclooxygenases 1, 2,
and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and
cyclooxygenase-2-selective inhibitors in rat tissues. J Pharmacol Exp Ther 2004; 310(2): 642–7.
31. Birmingham PK, Tobin MJ, Henthorn TK et al. Twenty-four-hour pharmacokinetics of rectal
acetaminophen in children: an old drug with new recommendations. Anesthesiology 1997; 87(2): 244–
52.
32. Van der Marel CD, Peters JWB, Bouwmeester NJ, Jacqz-Aigrain E, van den Anker JN, Tibboel D.
Rectal acetaminophen does not reduce morphine consumption after major surgery in young infants. Br
J Anaesth 2007; 98(3): 372–9.
33. Nahata MC, Durrell DE, Powell DA, Gupta N. Pharmacokinetics of ibuprofen in febrile children. Eur
J Clin Pharmacol 1991; 40(4): 427–8.
34. Collins SL, Moore RA, McQuay HJ, Wiffen PJ, Edwards JE. Single dose oral ibuprofen and
diclofenac for postoperative pain. Cochrane Database Syst Rev 2000; 2: CD001548.
35. Lesko S, Mitchell A. An assessment of the safety of pediatric ibuprofen. A practitioner-based
randomized clinical trial. JAMA 1995; 273(12): 929–33.
36. Reiff A, Lovell DJ, Adelsberg JV et al. Evaluation of the comparative efficacy and tolerability of
rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week
randomized controlled clinical trial with a 52-week open-label extension. J Rheumatol 2006; 33(5):
985–95.
37. Moiniche S, Romsing J, Dahl JB, Tramer MR. Nonsteroidal antiinflammatory drugs and the risk of
operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg 2003; 96(1):
68–77.
38. Krishna S, Hughes LF, Lin SY. Postoperative hemorrhage with nonsteroidal anti-inflammatory drug
use after tonsillectomy: a meta-analysis. Arch Otolaryngol Head Neck Surg 2003; 129(10): 1086–9.
39. Marret E, Flahault A, Samama CM, Bonnet F. Effects of postoperative, nonsteroidal,
antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled
trials. Anesthesiology 2003; 98(6): 1497–502.
40. Jirarattanaphochai K, Jung S. Nonsteroidal antiinflammatory drugs for postoperative pain
management after lumbar spine surgery: a meta-analysis of randomized controlled trials. J Neurosurg
Spine 2008; 9(1): 22–31.
41. Gupta A, Daggett C, Drant S, Rivero N, Lewis A. Prospective randomized trial of ketorolac after
congenital heart surgery. J Cardiothorac Vasc Anesth 2004; 18(4): 454–7.
42. Burd RS, Tobias JD. Ketorolac for pain management after abdominal surgical procedures in
infants. South Med J 2002; 95(3): 331–3.
43. Moffett BS, Wann TI, Carberry KE, Mott AR. Safety of ketorolac in neonates and infants after
cardiac surgery. Paediatr Anaesth 2006; 16(4): 424–8.
44. Nikanne E, Kokki H, Salo J, Linna TJ. Celecoxib and ketoprofen for pain management during
tonsillectomy: a placebo-controlled clinical trial. Otolaryngol Head Neck Surg 2005; 132(2): 287–94.
45. Pickering AE, Bridge HS, Nolan J, Stoddart PA. Double-blind, placebo-controlled analgesic study of
ibuprofen or rofecoxib in combination with paracetamol for tonsillectomy in children. Br J Anaesth 2002;
88(1): 72–7.
46. Sheeran PW, Rose JB, Fazi LM, Chiavacci R, McCormick L. Rofecoxib administration to paediatric
patients undergoing adenotonsillectomy. Paediatr Anaesth 2004; 14(7): 579–83.
47. Talbot JN, Happe HK, Murrin LC. Mu opioid receptor coupling to Gi/o proteins increases during
postnatal development in rat brain. J Pharmacol Exp Ther 2005; 314(2): 596–602.
48. Seatriz JV, Hammer RP Jr. Effects of opiates on neuronal development in the rat cerebral cortex.
Brain Res Bull 1993; 30(5-6): 523–7.
49. Zissen MH, Zhang G, McKelvy A, Propst JT, Kendig JJ, Sweitzer SM. Tolerance, opioid-induced
allodynia and withdrawal associated allodynia in infant and young rats. Neuroscience 2007; 144(1):
247–62.
50. Laprairie JL, Johns ME, Murphy AZ. Preemptive morphine analgesia attenuates the long-term
consequences of neonatal inflammation in male and female rats. Pediatr Res 2008; 64(6): 625–30.
51. Anand KJ, Hall RW, Desai N et al. Effects of morphine analgesia in ventilated preterm neonates:
primary outcomes from the NEOPAIN randomised trial. Lancet 2004; 363(9422): 1673–82.
52. Carbajal R, Lenclen R, Jugie M, Paupe A, Barton BA, Anand KJ. Morphine does not provide
adequate analgesia for acute procedural pain among preterm neonates. Pediatrics 2005; 115(6):
1494–500.
53. Durrmeyer X, Vutskits L, Anand KJS, Rimensberger PC. Use of analgesic and sedative drugs in the
NICU: integrating clinical trials and laboratory data. Pediatr Res 2010; 67(2): 117–27.
54. Anand KJS, Willson DF, Berger J et al. Tolerance and withdrawal from prolonged opioid use in
critically ill children. Pediatrics 2010; 125(5): e1208–25.
55. Williams DG, Patel A, Howard RF. Pharmacogenetics of codeine metabolism in an urban
population of children and its implications for analgesic reliability. Br J Anaesth 2002; 89(6): 839–45.
56. Ciszkowski C, Madadi P, Phillips MS, Lauwers AE, Koren G. Codeine, ultrarapid-metabolism
genotype, and postoperative death. N Engl J Med 2009; 361(8): 827–8.
57. Pokela ML, Anttila E, Seppala T, Olkkola KT. Marked variation in oxycodone pharmacokinetics in
infants. Paediatr Anaesth 2005; 15(7): 560–5.
58. Bouwmeester NJ, Hop WC, van Dijk M, Anand KJ, van den Anker JN, Tibboel D. Postoperative
pain in the neonate: age-related differences in morphine requirements and metabolism. Intensive Care
Med 2009; 29(11): 2009–15.
59. Simons SH, Roofthooft DW, van Dijk M et al. Morphine in ventilated neonates: its effects on arterial
blood pressure. Arch Dis Child Fetal Neonatal Ed 2006; 91(1): F46–51.
60. Collins JJ, Geake J, Grier HE et al. Patient-controlled analgesia for mucositis pain in children: a
three-period crossover study comparing morphine and hydromorphone. J Pediatr 1996; 129(5): 722–8.
61. McCann S, Yaksh TL, von Gunten CF. Correlation between myoclonus and the 3-glucuronide
metabolites in patients treated with morphine or hydromorphone: a pilot study. J Opioid Manage 2010;
6(2): 87–94.
62. Hong D, Flood P, Diaz G. The side-effects of morphine and hydromorphone patient-controlled
analgesia. Anesth Analg 2008; 107(4): 1384–9.
63. Davis AM, Inturrisi CE. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced
hyperalgesia. J Pharmacol Exp Ther 1999; 289(2): 1048–53.
64. Mercadante S, Casuccio A, Fulfaro F et al. Switching from morphine to methadone to improve
analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 2001; 19(11): 2898–904.
65. Berens RJ, Meyer MT, Mikhailov TA et al. A prospective evaluation of opioid weaning in opioiddependent pediatric critical care patients. Anesth Analg 2006; 102(4): 1045–50.
66. Roetman KJ, Welborn LG, Hannallah RS, Fink R, Norden JM, O'Donnell R. Evaluation of
awakening and recovery characteristics following anaesthesia with nitrous oxide and halothane
fentanyl or both for brief outpatient procedures in infants. Paediatr Anaesth 1997; 7(5): 391–7.
67. Singleton M, Rosen J, Fisher D. Plasma concentrations of fentanyl in infants, children and adults.
Can J Anaesth 1987; 34: 152–5.
68. Santeiro ML, Christie J, Stromquist C, Torres BA, Markowsky SJ. Pharmacokinetics of continuous
infusion fentanyl in newborns. J Perinatol 1997; 17(2): 135–9.
69. Schechter N, Weisman S, Rosenblum M, Bernstein B, Conard P. The use of oral transmucosal
fentanyl citrate for painful procedures in children. Pediatrics 1995; 95(3): 335–9.
70. Collins JJ, Dunkel IJ, Gupta SK et al. Transdermal fentanyl in children with cancer pain: feasibility,
tolerability, and pharmacokinetic correlates. J Pediatr 1999; 134(3): 319–23.
71. Lynn AM, Nespeca MK, Bratton SL, Shen DD. Intravenous morphine in postoperative infants:
intermittent bolus dosing versus targeted continuous infusions. Pain 2000; 88(1): 89–95.
72. Bouwmeester NJ, Anand KJ, van Dijk M, Hop WC, Boomsma F, Tibboel D. Hormonal and
metabolic stress responses after major surgery in children aged 0–3 years: a double-blind, randomized
trial comparing the effects of continuous versus intermittent morphine. Br J Anaesth 2001; 87(3): 390–
9.
73. Czarnecki ML, Salamon KS, Jastrowski Mano KE, Ferrise AS, Sharp M, Weisman SJ. A preliminary
report of parent/nurse-controlled analgesia (PNCA) in infants and preschoolers. Clin J Pain 2010;
27(2): 102–7.
74. Peters JW, Bandell Hoekstra IE, Huijer Abu-Saad H, Bouwmeester J, Meursing AE, Tibboel D.
Patient controlled analgesia in children and adolescents: a randomized controlled trial. Paediatr
Anaesth 1999; 9(3): 235–41.
75. Howard RF, Lloyd-Thomas A, Thomas M et al. Nurse-controlled analgesia (NCA) following major
surgery in 10,000 patients in a children's hospital. Paediatr Anaesth 2010; 20(2): 126–34.
76. Monitto CL, Greenberg RS, Kost-Byerly S et al. The safety and efficacy of parent-/nurse-controlled
analgesia in patients less than six years of age. Anesth Analg 2000; 91(3): 573–9.
77. Kehlet H. Postoperative opioid sparing to hasten recovery: what are the issues? Anesthesiology
2005; 102(6): 1083–5.
78. Berde C, Nurko S. Opioid side-effects – mechanism-based therapy. N Engl J Med 2008; 358(22):
2400–2.
79. Maxwell LG, Kaufmann SC, Bitzer S et al. The effects of a small-dose naloxone infusion on opioidinduced side-effects and analgesia in children and adolescents treated with intravenous patientcontrolled analgesia: a double-blind, prospective, randomized, controlled study. Anesth Analg 2005;
100(4): 953–8.
80. Nakatsuka N, Minogue SC, Lim J et al. Intravenous nalbuphine 50 microg x kg(-1) is ineffective for
opioid-induced pruritus in pediatrics. Can J Anaesth 2006; 53(11): 1103–10.
81. Roberts GW, Bekker TB, Carlsen HH, Moffatt CH, Slattery PJ, McClure AF. Postoperative nausea
and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth
Analg 2005; 101(5): 1343–8.
82. Wolfe J, Grier HE, Klar N et al. Symptoms and suffering at the end of life in children with cancer. N
Engl J Med 2000; 342(5): 326–33.
83. Ullrich CK, Dussel V, Hilden JM et al. Fatigue in children with cancer at the end of life. J Pain
Symptom Manage 2010; 40(4): 483–94.
84. Mazoit JX, Dalens BJ. Pharmacokinetics of local anaesthetics in infants and children. Clin
Pharmacokinet 2004; 43(1): 17–32.
85. Henderson K, Sethna NF, Berde CB. Continuous caudal anesthesia for inguinal hernia repair in
former preterm infants. J Clin Anesth 1993; 5(2): 129–33.
86. Berde CB. Convulsions associated with pediatric regional anesthesia. Anesth Analg 1992; 75(2):
164–6.
87. Kohane DS, Sankar WN, Shubina M, Hu D, Rifai N, Berde CB. Sciatic nerve blockade in infant,
adolescent, and adult rats: a comparison of ropivacaine with bupivacaine. Anesthesiology 1998; 89:
1199–208.
88. Lehr VT, Taddio A. Topical anesthesia in neonates: clinical practices and practical considerations.
Semin Perinatol 2007; 31(5): 323–9.
89. Shah V, Taddio A, Rieder MJ. Effectiveness and tolerability of pharmacologic and combined
interventions for reducing injection pain during routine childhood immunizations: systematic review and
meta-analyses. Clin Ther 2009; 31(Suppl 2): S104–51.
90. Taddio A, Ohlsson A, Einarson TR, Stevens B, Koren G. A systematic review of lidocaine–
prilocaine cream (EMLA) in the treatment of acute pain in neonates. Pediatrics 1998; 101(2): E1.
91. Lander JA, Weltman BJ, So SS. EMLA and amethocaine for reduction of children's pain associated
with needle insertion. Cochrane Database Syst Rev 2006; 3: CD004236.
92. Sethna NF, Verghese ST, Hannallah RS, Solodiuk JC, Zurakowski D, Berde CB. A randomized
controlled trial to evaluate S-Caine patch for reducing pain associated with vascular access in children.
Anesthesiology 2005; 102(2): 403–8.
93. Spanos S, Booth R, Koenig H, Sikes K, Gracely E, Kim IK. Jet injection of 1% buffered lidocaine
versus topical ELA-Max for anesthesia before peripheral intravenous catheterization in children: a
randomized controlled trial. Pediatr Emerg Care 2008; 24(8): 511–15.
94. Drasner K. Thoracic epidural anesthesia: asleep at the wheal? Anesth Analg 2004; 99(2): 578–9.
95. Llewellyn N, Moriarty A. The national pediatric epidural audit. Paediatr Anaesth 2007; 17(6): 520–
33.
96. Ecoffey C, Lacroix F, Giaufre E, Orliaguet G, Courreges P. Epidemiology and morbidity of regional
anesthesia in children: A follow-up one-year prospective survey of the French-Language Society of
Pediatric Anaesthesiologists (ADARPEF). Paediatr Anaesth 2010; 20(12): 1061–9.
97. Tsui BC, Suresh S. Ultrasound imaging for regional anesthesia in infants, children, and
adolescents: a review of current literature and its application in the practice of neuraxial blocks.
Anesthesiology 2010; 112(3): 719–28.
98. Tsui BC, Seal R, Koller J, Entwistle L, Haugen R, Kearney R. Thoracic epidural analgesia via the
caudal approach in pediatric patients undergoing fundoplication using nerve stimulation guidance.
Anesth Analg 2001; 93(5): 1152–5.
99. Tsui BC, Seal R, Koller J. Thoracic epidural catheter placement via the caudal approach in infants
by using electrocardiographic guidance. Anesth Analg 2002; 95(2): 326–30.
100. Tsui BC, Gupta S, Finucane B. Confirmation of epidural catheter placement using nerve
stimulation. Can J Anaesth 1998; 45(7): 640–4.
101. Larsson BA, Lonnqvist PA, Olsson GL. Plasma concentrations of bupivacaine in neonates after
continuous epidural infusion. Anesth Analg 1997; 84(3): 501–5.
102. De Negri P, Ivani G, Tirri T et al. A comparison of epidural bupivacaine, levobupivacaine, and
ropivacaine on postoperative analgesia and motor blockade. Anesth Analg 2004; 99(1): 45–8.
103. Rapp HJ, Molnar V, Austin S et al. Ropivacaine in neonates and infants: a population
pharmacokinetic evaluation following single caudal block. Paediatr Anaesth 2004; 14(9): 724–32.
104. McCann ME, Sethna NF, Mazoit JX et al. The pharmacokinetics of epidural ropivacaine in infants
and young children. Anesth Analg 2001; 93(4): 893–7.
105. Lonnqvist PA, Westrin P, Larsson BA et al. Ropivacaine pharmacokinetics after caudal block in 1–
8 year old children. Br J Anaesth 2000; 85(4): 506–11.
106. Yaster M, Aronoff D, Kornhauser DM, Pasternak LR, Jeffs RD. The pharmacokinetics of lidocaine
during caudal anesthesia in children. Anesthesiology 1985; 63(3A): A465.
107. Kakiuchi Y, Kohda Y, Miyabe M, Momose Y. Effect of plasma alpha1-acid glycoprotein
concentration on the accumulation of lidocaine metabolites during continuous epidural anesthesia in
infants and children. Int J Clin Pharmacol Ther 1999; 37(10): 493–8.
108. Taenzer AH, Pyke JB, McGrath SP, Blike GT. Impact of pulse oximetry surveillance on rescue
events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology 2010;
112(2): 282–7.
109. Collins JJ, Berde CB, Frost JA. Pain assessment and management. In: Wolfe J, Hinds P, Sourkes
B (eds) Textbook of Interdisciplinary Pediatric Palliative Care. 2011.
110. Collins JJ, Devine TD, Dick GS et al. The measurement of symptoms in young children with
cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7–12. J Pain
Symptom Manage 2002; 23(1): 10–16.
111. James PJ, Howard RF, Williams DG. The addition of ketamine to a morphine nurse- or patientcontrolled analgesia infusion (PCA/NCA) increases analgesic efficacy in children with mucositis pain.
Paediatr Anaesth 2010; 20(9): 805–11.
112. Krane EJ, Heller LB, Pomietto ML. Incidence of phantom sensation and pain in pediatric
amputees. Anesthesiology 1991; 75(3A): A691.
113. Ramachandran VS, Altschuler EL. The use of visual feedback, in particular mirror visual feedback,
in restoring brain function. Brain 2009; 132(Pt 7): 1693–710.
114. Collins JJ, Grier HE, Kinney HC, Berde CB. Control of severe pain in children with terminal
malignancy. J Pediatr 1995; 126(4): 653–7.
115. Collins JJ, Grier HE, Sethna NF, Wilder RT, Berde CB. Regional anesthesia for pain associated
with terminal pediatric malignancy. Pain 1996; 65(1): 63–9.
116. Berde C, Wolfe J. Pain, anxiety, distress, and suffering: interrelated, but not interchangeable. J
Pediatr 2003; 142(4): 361–3.
117. Quill TE, Dresser R, Brock DW. The rule of double effect – a critique of its role in end-of-life
decision making. N Engl J Med 1997; 337(24): 1768–71.
118. Yaster M, Kost-Byerly S, Maxwell LG. The management of pain in sickle cell disease. Pediatr Clin
North Am 2000; 47(3): 699–710.
119. Platt OS, Thorington BD, Brambilla DJ et al. Pain in sickle cell disease. Rates and risk factors. N
Engl J Med 1991; 325(1): 11–16.
120. Beyer JE. Judging the effectiveness of analgesia for children and adolescents during vasoocclusive events of sickle cell disease. J Pain Symptom Manage 2000; 19(1): 63–72.
121. Ravilly S, Robinson W, Suresh S, Wohl ME, Berde CB. Chronic pain in cystic fibrosis. Pediatrics
1996; 98(4 Pt 1): 741–7.
122. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system
to damage. Annu Rev Neurosci 2009; 32: 1–32.
123. McCann ME, Waters P, Goumnerova LC, Berde C. Self-mutilation in young children following
brachial plexus birth injury. Pain 2004; 110(1–2): 123–9.
124. Howard RF, Walker SM, Mota PM, Fitzgerald M. The ontogeny of neuropathic pain: postnatal
onset of mechanical allodynia in rat spared nerve injury (SNI) and chronic constriction injury (CCI)
models. Pain 2005; 115(3): 382–9.
125. Moss A, Beggs S, Vega-Avelaira D et al. Spinal microglia and neuropathic pain in young rats. Pain
2007; 128(3): 215–24.
126. Naleschinski D, Arning K, Baron R. Fabry disease – pain doctors have to find the missing ones.
Pain 2009; 145(1–2): 10–1.
127. Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrollment: definition and effects of
enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. Br
J Clin Pharmacol 2008; 66(2): 266–75.
128. Tsapakis EM, Soldani F, Tondo L, Baldessarini RJ. Efficacy of antidepressants in juvenile
depression: meta-analysis. Br J Psychiatry 2008; 193(1): 10–17.
129. Patorno E, Bohn RL, Wahl PM et al. Anticonvulsant medications and the risk of suicide, attempted
suicide, or violent death. JAMA 2010; 303(14): 1401–9.
130. Sirianni AJ, Osterhoudt KC, Calello DP et al. Use of lipid emulsion in the resuscitation of a patient
with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med
2008; 51(4): 412–15.
131. Sung HE, Richter L, Vaughan R, Johnson PB, Thom B. Nonmedical use of prescription opioids
among teenagers in the United States: trends and correlates. J Adolesc Health 2005; 37(1): 44–51.
132. Fredheim OM, Log T, Olsen W, Skurtveit S, Sagen O, Borchgrevink PC. Prescriptions of opioids
to children and adolescents; a study from a national prescription database in Norway. Paediatr Anaesth
2010; 20(6): 537–44.
133. Bernstein BH, Singsen BH, Kent JT et al. Reflex neurovascular dystrophy in childhood. J Pediatr
1978; 93: 211–15.
134. Harden RN. Objectification of the diagnostic criteria for CRPS. Pain Med 2010; 11(8): 1212–15.
135. Seifert F, Kiefer G, DeCol R, Schmelz M, Maihofner C. Differential endogenous pain modulation in
complex regional pain syndrome. Brain 2009; 132(Pt 3): 788–800.
136. Maihofner C, Baron R, DeCol R et al. The motor system shows adaptive changes in complex
regional pain syndrome. Brain 2007; 130(Pt 10): 2671–87.
137. Wilder RT, Berde CB, Wolohan M, Vieyra MA, Masek BJ, Micheli LJ. Reflex sympathetic
dystrophy in children. Clinical characteristics and follow-up of seventy patients. J Bone Joint Surg Am
1992; 74A(6): 910–19.
138. Sherry DD, Wallace CA, Kelley C, Kidder M, Sapp L. Short- and long-term outcomes of children
with complex regional pain syndrome type I treated with exercise therapy. Clin J Pain 1999; 15(3):
218–23.
139. Lebel A, Becerra L, Wallin D et al. fMRI reveals distinct CNS processing during symptomatic and
recovered complex regional pain syndrome in children. Brain 2008; 131(Pt 7): 1854–79.
140. Sava S, Lebel AA, Leslie DS et al. Challenges of functional imaging research of pain in children.
Mol Pain 2009; 5: 30.
141. Lee BH, Scharff L, Sethna NF et al. Physical therapy and cognitive-behavioral treatment for
complex regional pain syndromes. J Pediatr 2002; 141(1): 135–40.
142. Dadure C, Motais F, Ricard C, Raux O, Troncin R, Capdevila X. Continuous peripheral nerve
blocks at home for treatment of recurrent complex regional pain syndrome I in children. Anesthesiology
2005; 102(2): 387–91.
143. Jones GT, Macfarlane GJ. Predicting persistent low back pain in schoolchildren: a prospective
cohort study. Arthritis Rheum 2009; 61(10): 1359–66.
144. Rodriguez-Navarro AJ, Berde C, Wiedmaier G et al. Comparison of neosaxitoxin versus
bupivacaine via port infiltration for postoperative analgesia following laparoscopic cholecystectomy: a
randomized, double blind trial. Reg Anesth Pain Med 2011; 36(2): 103–9.
145. Bogduk N. Evidence-informed management of chronic low back pain with facet injections and
radiofrequency neurotomy. Spine J 2008; 8(1): 56–64.
146. Apley J, Naish N. Recurrent abdominal pains: a field survey of 1,000 school children. Arch Dis
Child 1958; 33: 165.
147. Baber KF, Anderson J, Puzanovova M, Walker LS. Rome II versus Rome III classification of
functional gastrointestinal disorders in pediatric chronic abdominal pain. J Pediatr Gastroenterol Nutr
2008; 47(3): 299–302.
148. Palermo TM, Eccleston C, Lewandowski AS, Williams AC, Morley S. Randomized controlled trials
of psychological therapies for management of chronic pain in children and adolescents: an updated
meta-analytic review. Pain 2010; 148(3): 387–97.
149. Bahar RJ, Collins BS, Steinmetz B, Ament ME. Double-blind placebo-controlled trial of
amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr 2008; 152(5): 685–
9.
150. Saps M, Youssef N, Miranda A et al. Multicenter, randomized, placebo-controlled trial of
amitriptyline in children with functional gastrointestinal disorders. Gastroenterology 2009; 137(4): 1261–
9.
151. Saps M, di Lorenzo C. Pharmacotherapy for functional gastrointestinal disorders in children. J
Pediatr Gastroenterol Nutr 2009; 48(Suppl 2): S101–3.
152. Lewis DW, Ashwal S, Dahl G et al. Practice parameter: evaluation of children and adolescents
with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of
Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002; 59(4): 490–8.
153. Graf WD, Kayyali HR, Alexander JJ, Simon SD, Morriss MC. Neuroimaging-use trends in
nonacute pediatric headache before and after clinical practice parameters. Pediatrics 2008; 122(5):
e1001–5.
154. Graf WD, Kayyali HR, Abdelmoity AT, Womelduff GL, Williams AR, Morriss MC. Incidental
neuroimaging findings in nonacute headache. J Child Neurol 2010; 25(10): 1182–7.
155. Robberstad L, Dyb G, Hagen K, Stovner LJ, Holmen TL, Zwart JA. An unfavorable lifestyle and
recurrent headaches among adolescents: the HUNT study. Neurology 2010; 75(8): 712–17.
156. Hershey AD, Lipton RB. Adolescents get as well as they give: population perspectives on chronic
daily headaches. Neurology 2006; 66(2): 160–1.
157. Lewis DW, Winner P. The pharmacological treatment options for pediatric migraine: an evidencebased appraisal. NeuroRx 2006; 3(2): 181–91.
158. Bakola E, Skapinakis P, Tzoufi M, Damigos D, Mavreas V. Anticonvulsant drugs for pediatric
migraine prevention: an evidence-based review. Eur J Pain 2009; 13(9): 893–901.
159. Lewis D, Winner P, Saper J et al. Randomized, double-blind, placebo-controlled study to evaluate
the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
Pediatrics 2009; 123(3): 924–34.
160. Hogestatt E, Jonsson Bo A, Ermund A et al. Conversion of acetaminophen to the bioactive nacylphenolamine AM404 via fatty acid amide hydrolase dependent arachidonic acid conjugated in the
nervous system. J Biol Chem 2005.